StockMarketWire.com - IP Group, the developer of intellectual property-based businesses, said its portfolio company Oxford Nanopore Technologies struck an agreement with the UK to roll out its Covid-19 test.
Under the agreement, an initial 450k LamPORE SARS-CoV-2 tests would be made available for use by a number of NHS testing laboratories.
This launch would support the UK's efforts to 'manage the continued reduction of COVID-19 and containment of new cases, now and through the winter cold and flu season,' the company said.
At 8:26am: [LON:IPO] Ip Group PLC share price was +8.9p at 75.4p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.